PTPRC and Alzheimer disease: The LPS treatment paradigm used in the present study has previously induced inflammation in the brain of aged 3xTg-AD mice as demonstrated by more CD45 + infiltrated macrophages and microglia and by increased levels of pro-inflammatory cytokines with no effect on amyloid plaque load47.